Key result
IRAG deficiency in murine platelets enhanced aggregability and severely impaired NO/cGMP-dependent inhibition of granule secretion, aggregation, and adhesion, leading to reduced bleeding time.
Why the study?
Does IRAG deficiency affect NO/cGMP-dependent inhibition of platelet activation in murine models?
Does IRAG deficiency affect NO/cGMP-dependent inhibition of platelet activation in murine models?
Signaling via IRAG is essential for NO/cGMP-dependent inhibition of platelet activation, aggregation, and adhesion in murine models.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications; hypothesis-generating for IRAG modulation of human platelet reactivity.
Platelet activation is strongly affected by nitric oxide/cyclic GMP (NO/cGMP) signaling involving cGMP-dependent protein kinase I (cGKI). Previously it was shown that interaction of the cGKI substrate IRAG with InsP(3)RI is essential for NO/cguanosine monophosphate (GMP)-dependent inhibition of platelet aggregation in vitro and in vivo. However, the role of Inositol-trisphosphate receptor associated cGMP kinase substrate (IRAG) for platelet adhesion or granule secretion was unknown. Here, we analysed the functional role of IRAG for platelet activation. Murine IRAG-deficient platelets displayed enhanced aggregability towards several agonists (collagen, thrombin and TxA2). NO- or cGMP-dependent inhibition of agonist induced ATP- or 5-HT secretion from dense granules, and P-selectin secretion from alpha granules was severely affected in IRAG-deficient platelets. Concomitantly, the effect of NO/cGMP on platelet aggregation was strongly reduced in IRAG-deficient platelets. Furthermore, GPIIb/IIIa-mediated adhesion of platelets to fibrinogen could only weakly be inhibited in IRAG-deficient mice contrary to wild-type (WT) mice. Our results suggest that signaling via IRAG is essential for NO/cGMP-dependent inhibition of platelet activation regarding granule secretion, aggregation and adhesion. This platelet disorder might cause that the bleeding time of IRAG-deficient mice was reduced.
No takes yet. Share an insight, caveat, or question.
Schinner et al. (2011) studied Platelet activation. IRAG deficiency vs. Wild-type (WT) mice was evaluated on Platelet activation (granule secretion, aggregation, and adhesion). IRAG deficiency in murine platelets enhanced aggregability and severely impaired NO/cGMP-dependent inhibition of granule secretion, aggregation, and adhesion, leading to reduced bleeding time.
Synapse has enriched 10 related papers. Consider them for comparative context: